Yumeng Zhang

8PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursInnate immunityGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 03, 2026
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma.

|May 13, 2026
Revisiting the Origins of Cutaneous T-Cell Lymphoma: A Progenitor-Based Model.

|Mar 28, 2024
High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer.

Yumeng Zhang, Lancia Darville, Stephanie Hogue

|Apr 28, 2023
Clinical Spectrum, Radiological Findings, and Outcomes of Severe Toxoplasmosis in Immunocompetent Hosts: A Systematic Review.

John Layton, Danai-Christina Theiopoulou, David Rutenberg

|Feb 18, 2022
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?

Somedeb Ball, Akriti G Jain, Luis E Aguirre

|Sep 01, 2021
Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center.

Yumeng Zhang, Lucia Seminario-Vidal, Christa Varnadoe

Pageof 2

Frequent Collaborators

2 joint publications

Ning Dong

1 joint publications

Todd C Knepper

1 joint publications

Somedeb Ball

1 joint publications

Onyee Chan